ERCC2 and neoplasm: According to that, we hypothesized that miR-92a-3p triggers EMT in tumor cells through the activation of β-catenin, leading to the upregulation of DPYD, TYMS, MTHFR, ERCC1, ERCC2, and XRCC1 expression.